Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
IDdb Data Sources


 

IDdb now contains:
  • 23,312 investigational drugs
  • 107,800 therapeutic patents
  • 11,365 chemical structures (drugs)
  • 69,445 chemical structures (patents)
  • 25,909 companies/institutes
  • 530,861 references
  • 4,768 meeting reports
  • 2496 drug evaluations

This information is supplemented and updated daily.

Information is compiled from the following sources:

Patents
Scientific Meetings
Scientific Literature
Commercial Sources and Direct Company Communications

SOURCES

Patents
Approximately 180 new patents are added weekly, alerting researchers to potential competitor compounds and providing a complete picture of competitors' early research portfolios.

Therapeutic patents filed through the major patent routes (the World, European, American, Japanese and British patent offices) are selected for abstracting. A summary and sample chemical structure, if appropriate, are added to IDdb - usually within a week of publication.

This patent information is also available in Thomson Current Drugs' weekly patent monitoring service, Patent fast alert.

Scientific Meetings
More drugs are reported at meetings than anywhere else - read about it first in IDdb.
IDdb has one of the fastest and probably the most comprehensive meeting report services. Utilizing a network of up to 2,000 scientists as well as our own in-house editors, we cover over 300 global meetings every year. In excess of 400 reports are added to IDdb from these meetings and the underlying information in thousands of drug and company reports is updated.

Our reporters interview presenters at oral and poster sessions so they can clearly communicate the scientist's perspective.

The reporting is fast; IDdb daily reports are posted overnight for major conferences and other reports are posted within two weeks of the conference finishing.

Download IDdb meeting coverage for 2005 (as of January 2005)

Scientific Literature
Biomedical and pharmaceutical literature is covered
Approximately 700 new references are added each week, alerting users to recently published drug information and providing a comprehensive bibliography for each drug.

Priority lists of approximately 100 scientific journals are directly scanned for rapid coverage by our in-house editorial team. Back-up scanning of the core biomedical and chemical bibliographic databases provides coverage of thousands of other journals.

Commercial Sources and Direct Company Communication's
Direct company communications, annual reports and press releases

Company press releases provide a vital source of drug and company news - especially for IDdb Daily Alerts. As with all information sources in IDdb, the full text of the original is available via convenient hyperlinks. Daily newswires, industry newsletters, analyst and annual reports are scanned and the editors also communicate directly with companies in order to validate the gathered data, and where possible, collect and verify more information.


 


 

Additional Information

Further Resources

Subscribe

Support Center

Visit our Support Center - packed with support, reference and training information to help you use our products effectively.

 
Disclaimer | Terms of Use
Privacy Policy | Copyright